NextCure, Inc. Profile Avatar - Palmy Investing

NextCure, Inc.

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is i…

Biotechnology
US, Beltsville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

NextCure, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

NextCure, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of NextCure, Inc..

End of NXTC's Analysis
CIK: 1661059 CUSIP: 65343E108 ISIN: US65343E1082 LEI: - UEI: -
Secondary Listings
NXTC has no secondary listings inside our databases.